About Autz IP

With a degree in chemical engineering and biotechnology, Ms. Autz has extensive experience representing leading pharmaceutical, biotechnology and medical device clients.

Ms. Autz has over 14 years of experience in intellectual property law, both at a leading national intellectual property boutique and an Am Law 100 firm.  Most recently, Ms. Autz has worked as a legal consultant for an Am Law 100 firm.

Ms. Autz frequently represents high-profile pharmaceutical companies in patent litigations, many under the Hatch-Waxman Act, in the areas of biotechnology, pharmaceuticals, and the chemical arts.  She has experience in all aspects of patent litigation, including pre-suit investigations, jury trials, and appeals before the Federal Circuit, as well as international arbitration.

She has handled matters involving a wide array of technologies, including small molecule drugs, pharmaceutical formulations, biosimilar drugs, and eukaryotic protein expression technologies.  Specifically, Ms. Autz has worked on critical matters concerning anti-cancer therapies, anti-platelet treatment, drugs for treating attention deficit disorder and hair growth, eukaryotic protein expression technology, treatment for symptoms of Sjögren’s Syndrome, cancer treatments, antibody phage technology and oral contraceptives.